{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:40:18Z","timestamp":1792802418341,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","award":["9\/00042"],"award-info":[{"award-number":["9\/00042"]}],"id":[{"id":"https:\/\/ror.org\/05ex5vz81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181081","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T13:39:35Z","timestamp":1501076375000},"page":"e0181081","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":161,"title":["Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2\/M cell cycle arrest"],"prefix":"10.1371","volume":"12","author":[{"given":"Navin","family":"Sarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganna V.","family":"Kalayda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Mannewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindrich","family":"Cinatl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rothweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Saafan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph A.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Jaehde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-7509","authenticated-orcid":true,"given":"Roland","family":"Fr\u00f6tschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"LA Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"S Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","article-title":"Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group","volume":"26","author":"J Pignon","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","article-title":"Systems biology of cisplatin resistance: past, present and future","volume":"5","author":"L Galluzzi","year":"2014","journal-title":"Cell Death Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"ZH Siddik","year":"2003","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.59.4.657","article-title":"Is cisplatin-induced cell death always produced by apoptosis","volume":"59","author":"VM Gonzalez","year":"2001","journal-title":"Mol Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1179\/1973947812Y.0000000056","article-title":"Activation of ERK1\/2 and Akt is associated with cisplatin resistance in human lung cancer cells","volume":"25","author":"M Wang","year":"2013","journal-title":"J Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.18632\/oncotarget.1891","article-title":"Molecular pathways and therapeutic targets in lung cancer","volume":"5","author":"E Shtivelman","year":"2014","journal-title":"Oncotarget"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1038\/cddis.2011.129","article-title":"Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells","volume":"2","author":"M Michaelis","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"25892","DOI":"10.1038\/srep25892","article-title":"Effects of ADMA on gene expression and metabolism in serum-starved LoVo cells","volume":"6","author":"N Zheng","year":"2016","journal-title":"Sci Rep"},{"key":"ref11","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"DA Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20150517","article-title":"Regulation of the p53 response and its relationship to cancer","volume":"469","author":"DW Meek","year":"2015","journal-title":"Biochem J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"36031","DOI":"10.1074\/jbc.274.51.36031","article-title":"Regulation of the p53 Tumor Suppressor Protein","volume":"274","author":"M Oren","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-04-3995","article-title":"Lost in transcription: p21 repression, mechanisms, and consequences","volume":"65","author":"AL Gartel","year":"2005","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cncr.22743","article-title":"Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer","volume":"110","author":"Y Wu","year":"2007","journal-title":"Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-4-18","article-title":"ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines","volume":"4","author":"DA Weaver","year":"2005","journal-title":"Mol Cancer"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/07357909209032755","article-title":"New Therapies for Ovarian Cancer","volume":"10","author":"RJ Schilder","year":"2009","journal-title":"Cancer Investigation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e65309","DOI":"10.1371\/journal.pone.0065309","article-title":"The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell","volume":"8","author":"Y Yang","year":"2013","journal-title":"PLoS One"},{"key":"ref20","first-page":"750","article-title":"Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer","volume":"15","author":"MJ Millward","journal-title":"J Clin Oncol. 1997"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0009-9236(03)00008-0","article-title":"Cisplatin tumor concentrations after intra-arterial cisplatin infusion or embolization in patients with oral cancer","volume":"73","author":"I Tegeder","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bcp.2006.10.003","article-title":"Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells","volume":"73","author":"J Zisowsky","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0305-7372(90)90081-P","article-title":"The role of detoxifying systems in resistance of tumor cells to cisplatin and adriamycin","volume":"17","author":"C Meijer","year":"1990","journal-title":"Cancer Treat Rev"},{"key":"ref24","first-page":"3237","article-title":"Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin","volume":"51","author":"K Kasahara","year":"1991","journal-title":"Cancer Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/carcin\/15.6.1167","article-title":"Acquired resistance to cisplatin and doxorubicin in a small cell lung cancer cell line is correlated to elevated expression of glutathione-linked detoxification enzymes","volume":"15","author":"XY Hao","year":"1994","journal-title":"Carcinogenesis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2010.05.010","article-title":"The platinum-based treatments for advanced non-small cell lung cancer, is low\/negative ERCC1 expression better than high\/positive ERCC1 expression? A meta-analysis","volume":"70","author":"S Chen","year":"2010","journal-title":"Lung Cancer"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"L Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gpb.2014.10.003","article-title":"Pharmacogenomics of cisplatin sensitivity in non-small cell lung cancer","volume":"12","author":"MC Rose","year":"2014","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e54193","DOI":"10.1371\/journal.pone.0054193","article-title":"Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature","volume":"8","author":"MP Barr","year":"2013","journal-title":"PLoS One"},{"key":"ref30","first-page":"4760","article-title":"Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy","volume":"55","author":"N Zeng-Rong","year":"1995","journal-title":"Cancer Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0169-5002(03)00151-X","article-title":"Genetic testing for chemotherapy in non-small cell lung cancer","volume":"41","author":"R Rosell","year":"2003","journal-title":"Lung Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4137\/BMI.S485","article-title":"Excision Repair Cross-Complementation Group 1 Enzyme as a Molecular Determinant of Responsiveness to Platinum-Based Chemotherapy for non Small-Cell Lung Cancer","volume":"3","author":"G Mountzios","year":"2008","journal-title":"Biomark Insights"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"CJ Bakkenist","year":"2003","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1097-2765(01)00284-2","article-title":"p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis","volume":"8","author":"S Okamura","year":"2001","journal-title":"Mol Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fgene.2013.00080","article-title":"Tumor Protein 53-Induced Nuclear Protein 1 Enhances p53 Function and Represses Tumorigenesis","volume":"4","author":"J Shahbazi","year":"2013","journal-title":"Front Genet"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"44185","DOI":"10.1074\/jbc.M105647200","article-title":"Molecular and functional characterization of the stress-induced protein (SIP) gene and its two transcripts generated by alternative splicing. SIP induced by stress and promotes cell death","volume":"276","author":"R Tomasini","year":"2001","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3748\/wjg.v12.i10.1597","article-title":"Effect of gemcitabine on the expression of apoptosis-related genes in human pancreatic cancer cells","volume":"12","author":"P Jiang","year":"2006","journal-title":"World J Gastroenterol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1038\/sj.onc.1208951","article-title":"TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity","volume":"24","author":"R Tomasini","year":"2005","journal-title":"Oncogene"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/nar\/gkh541","article-title":"The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation","volume":"32","author":"G Wang","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0921-8777(99)00068-3","article-title":"Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition","volume":"459","author":"EC Friedberg","year":"2000","journal-title":"Mutat Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"13200","DOI":"10.1073\/pnas.0503133102","article-title":"Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis","volume":"102","author":"MC Hollander","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/0008-5472.CAN-08-2981","article-title":"Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways","volume":"69","author":"S Saviozzi","year":"2009","journal-title":"Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.7973727","article-title":"Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen","volume":"266","author":"ML Smith","year":"1994","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"21951","DOI":"10.1074\/jbc.M011303200","article-title":"The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts","volume":"276","author":"RE Shackelford","year":"2001","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1073\/pnas.96.7.3706","article-title":"GADD45 induction of a G2\/M cell cycle checkpoint","volume":"96","author":"XW Wang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11010-015-2458-3","article-title":"Effects of flavonoids on expression of genes involved in cell cycle regulation and DNA replication in human fibroblasts","volume":"407","author":"M Moskot","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ol.2015.3882","article-title":"GADD45A expression is correlated with patient prognosis in esophageal cancer","volume":"11","author":"H Ishiguro","year":"2016","journal-title":"Oncol Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1038\/cddis.2012.211","article-title":"Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK\/ATM activation and diminished cell cycle arrest","volume":"4","author":"L Lundholm","year":"2013","journal-title":"Cell Death Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lfs.2015.01.011","article-title":"Cisplatin resistance in human lung cancer cells is linked with dysregulation of cell cycle associated proteins","volume":"124","author":"S Horibe","year":"2015","journal-title":"Life Sci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cell.2009.04.050","article-title":"Modes of p53 regulation","volume":"137","author":"J Kruse","year":"2009","journal-title":"Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","article-title":"Correlation of mRNA and protein in complex biological samples","volume":"583","author":"T Maier","year":"2009","journal-title":"FEBS Lett"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T13:04:31Z","timestamp":1569935071000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181081"}},"subtitle":[],"editor":[{"given":"Aamir","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181081","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}